Jun 16, 2022 / 03:40PM GMT
Madhu Sudhan Kumar - Goldman Sachs Group, Inc., Research Division - Research Analyst
Thank you everyone for joining us today at the Goldman Sachs Global Healthcare Conference. Really thrilled to be joined by Simona King from Passage Bio to give us some update -- obviously the company's kind of in a point of transition so it's good to have someone join us and give us some update on where things are.
Simona King - Passage Bio, Inc. - CFO & Corporate Secretary
Excellent. Great to be here and thanks for having me.
Questions and Answers:
Madhu Sudhan Kumar - Goldman Sachs Group, Inc., Research Division - Research AnalystGreat. And I'll start at a very high level because I feel like with all these new biotechnology companies, it's good to have a high level view of the company. Walk us through Passage's approach to central nervous system AAV gene therapy and we could start I guess focus both on the technologies you are using but also some of the delivery methods that are kind of differentiating for Passage as
Trustpilot
